Lipocine Inc.

NAS: LPCN

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders

/marketstate/country/us

Lipocine Inc.

Market open

--Real time quotes

Jun 6, 2023, 11:07 a.m.

LPCN

/zigman2/quotes/202742746/composite

4.51

Change

+0.05 +1.12%

Volume

Volume 1,021

Real time quotes

/zigman2/quotes/202742746/composite

Previous close

$ 4.46

$ 4.51

Change

+0.05 +1.12%

Day low

Day high

$4.43

$4.64

52 week low

52 week high

$3.30

$16.15

Income Statement Balance Sheet Cash Flow Statement

Annual Financials for Lipocine Inc.

View Ratios

Fiscal year is January-December. All values USD millions.	2018	2019	2020	2021	2022	5-year trend
Sales/Revenue	428,031	164,990	-	16.14M	500,000
Sales Growth	-	-61.45%	-	-	-96.90%
Cost of Goods Sold (COGS) incl. D&A	-	-	3,554	380	9,453
COGS excluding D&A	-	-	-	-	-
Depreciation & Amortization Expense	18,595	15,443	3,554	380	9,453
Depreciation	18,595	15,443	3,554	380	9,453
Amortization of Intangibles	-	-	-	-	-
COGS Growth	-	-	-	-89.31%	2,387.63%
Gross Income	-	-	(3,554)	16.14M	490,547
Gross Income Growth	-	-	-	454,249.07%	-96.96%
Gross Profit Margin	-	-	-	-	98.11%	NA

	2018	2019	2020	2021	2022	5-year trend
SG&A Expense	11.74M	13.05M	17.99M	12.99M	12.61M
Research & Development	6.46M	7.45M	9.74M	7.67M	8.55M
Other SG&A	5.27M	5.6M	8.25M	5.33M	4.06M
SGA Growth	-	11.20%	37.88%	-27.78%	-2.96%
Other Operating Expense	-	-	-	-	-
Unusual Expense	-	(236,400)	2.66M	3.64M	(815,940)
EBIT after Unusual Expense	-	(12.66M)	(20.65M)	(498,610)	(11.3M)
Non Operating Income/Expense	-	-	-	-	-
Non-Operating Interest Income	459,497	-	75,650	67,700	572,578
Equity in Affiliates (Pretax)	-	-	-	-	-
Interest Expense	793,000	343,254	386,618	203,292	27,098
Interest Expense Growth	-	-56.71%	12.63%	-47.42%	-86.67%
Gross Interest Expense	793,000	343,254	386,618	203,292	27,098
Interest Capitalized	-	-	-	-	-
Pretax Income	(11.66M)	(13.01M)	(20.96M)	(634,199)	(10.76M)
Pretax Income Growth	-	-11.56%	-61.18%	96.97%	-1,596.31%
Pretax Margin	-	-	-	-	-2,151.59%	NA
Income Tax	700	200	200	200	681
Income Tax - Current Domestic	700	200	200	200	681
Income Tax - Current Foreign	-	-	-	-	-
Income Tax - Deferred Domestic	-	-	-	-	-
Income Tax - Deferred Foreign	-	-	-	-	-
Income Tax Credits	-	-	-	-	-
Equity in Affiliates	-	-	-	-	-
Other After Tax Income (Expense)	-	-	-	-	-
Consolidated Net Income	(11.66M)	(13.01M)	(20.96M)	(634,399)	(10.76M)
Minority Interest Expense	-	-	-	-	-
Net Income	(11.66M)	(13.01M)	(20.96M)	(634,399)	(10.76M)
Net Income Growth	-	-11.56%	-61.18%	96.97%	-1,595.88%
Net Margin Growth	-	-	-	-	-2,151.73%	NA
Extraordinaries & Discontinued Operations	-	-	-	-	-
Extra Items & Gain/Loss Sale Of Assets	-	-	-	-	-
Cumulative Effect - Accounting Chg	-	-	-	-	-
Discontinued Operations	-	-	-	-	-
Net Income After Extraordinaries	(11.66M)	(13.01M)	(20.96M)	(634,399)	(10.76M)
Preferred Dividends	-	-	-	-	-
Net Income Available to Common	(11.66M)	(13.01M)	(20.96M)	(634,399)	(10.76M)
EPS (Basic)	(9.28)	(8.54)	(6.40)	(0.12)	(2.07)
EPS (Basic) Growth	-	7.97%	25.09%	98.06%	-1,566.16%
Basic Shares Outstanding	1.26M	1.52M	3.28M	5.11M	5.2M
EPS (Diluted)	(9.28)	(8.54)	(6.40)	(0.12)	(2.07)
EPS (Diluted) Growth	-	7.97%	25.09%	98.06%	-1,566.16%
Diluted Shares Outstanding	1.26M	1.52M	3.28M	5.11M	5.2M
EBITDA	(11.31M)	(12.88M)	(17.99M)	3.15M	(12.11M)
EBITDA Growth	-	-13.95%	-39.64%	117.48%	-484.95%
EBITDA Margin	-	-	-	-	-2,421.99%	NA

MarketWatch.com

Follow MarketWatch
RSS
Podcasts

Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.

Lipocine Inc.

Annual Financials for Lipocine Inc.

Latest News

dow

nasdaq

s&p 500

Kiosk